AKTX-102 Investigational CEACAM5-targeting antibody-drug conjugate combining a tumor-directed antibody with the PH1 RNA-splicing payload, in preclinical development.
Visit productCosigns Received
Be the first Cosign
Put your name behind AKTX-102.
Add it to your Products I use list and share why you use it.